Research by Dexcom has found that 79% of people struggle to keep their glucose levels in range, and that almost half (45%) don’t understand what a Hybrid Closed Loop System (HCL) is or how it could benefit them.
Sometimes known as an ‘artificial pancreas’, an HCL system works by linking an insulin pump and continuous glucose monitor (CGM) with a computer algorithm that can calculate the amount of insulin someone needs based on their blood glucose readings.
Dexcom’s research follows the new Technology Appraisal (TA) from NICE which provides detailed guidance for HCL systems usage. The new TA impacts an eligible population of over 150,000 people living with Type 1 diabetes in England, providing access to HCL systems.
The Dexcom research showed that 99% of healthcare providers expect the NICE TA to somewhat or significantly help change the lives of people living with Type 1 diabetes for the better.
Karen Baxter, VP for UK Ireland Benelux Spain and France for Dexcom commented: “It is clear from our research that so many more people could benefit from HCL. Every single person (100%) surveyed with Type 1 diabetes said that being on an HCL system has reduced the burden of managing their diabetes and 98% of healthcare practitioners say they would want all people with Type 1 diabetes to have access to HCL.”
To support healthcare professionals with their understanding of the benefits of HCL systems for patients with diabetes, Dexcom has worked with the clinical experts at the Diabetes Technology Network (DTN) to launch a series of education modules encompassing everything they need to know about the technology.
To sign up for these modules, CLICK HERE.
